{"id":628,"date":"2014-01-01T12:06:00","date_gmt":"2014-01-01T11:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2014\/statine-senken-das-cholesterin-und-auch-die-fitness"},"modified":"2014-01-01T12:06:00","modified_gmt":"2014-01-01T11:06:00","slug":"statine-senken-das-cholesterin-und-auch-die-fitness","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2014\/statine-senken-das-cholesterin-und-auch-die-fitness","title":{"rendered":"Statine senken das Cholesterin \u2026 und auch die Fitness?"},"content":{"rendered":"<p>Was praktisch t\u00e4tige \u00c4rzte und Physiotherapeuten vermuten, wird nun auch in einigen aktuellen Untersuchungen konkreter: Statine werden von mehr Patienten nicht toleriert als bislang angenommen. Nach den gro\u00dfen Statin-Studien der vergangenen Jahre ist nach der Literatur von einer Inzidenz der Statin-Myopathie von 1,5-5% auszugehen (1, 2). Das trifft wohl auch in dieser H\u00e4ufigkeit zu, wenn [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Was praktisch t\u00e4tige \u00c4rzte und Physiotherapeuten vermuten, wird nun auch in einigen aktuellen Untersuchungen konkreter: Statine werden von mehr Patienten nicht toleriert als bislang angenommen. Nach den gro\u00dfen Statin-Studien der vergangenen Jahre ist nach der Literatur von einer Inzidenz der Statin-Myopathie von 1,5-5% auszugehen (1, 2). Das trifft wohl auch in dieser H\u00e4ufigkeit zu, wenn [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1046,1274,451,449,1461,1166,455,453,456,454,1462,1050,256,1167,801,1463,506,1043,505,443,254,253],"class_list":["post-628","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-atorvastatin","tag-cholesterin","tag-cholesterinsynthese-hemmer","tag-cse-hemmer","tag-fitness","tag-fluvastatin","tag-hmg-coa-reduktase-hemmer","tag-hypercholesterinaemie","tag-lipidsenker","tag-lovastatin","tag-myalgie","tag-myopathie","tag-nebenwirkungen","tag-pitavastatin","tag-pravastatin","tag-primo-studie","tag-rhabdomyolyse","tag-rosuvastatin","tag-simvastatin","tag-statine","tag-uaw","tag-unerwuenschte-arzneimittelwirkungen"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=628"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/628\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}